Table 3.
Procedure outcomes-Follow up data of groups- Inducible group -Patients who underwent AICD had lower sudden death and all-cause mortality as compared to medical follow up group (AICD- Automated implantable cardioverter defibrillator, VT-Ventricular tachycardia).
| INDUCIBLE (n = 79) |
p value (AICD vs medical follow up) | NON INDUCIBLE (n = 90) |
p value (AICDvs medical follow up) | ||||
|---|---|---|---|---|---|---|---|
| AICD (n = 42) | ABLATION (n = 16) | MEDICAL FOLLOW UP (n = 21) | AICD (n = 21) | MEDICAL FOLLOW UP (n = 69) | |||
| ALL CAUSE MORTALITY | 5 (11.90%) | 2 (16.67%) | 8 (38.09%) | 0.022 | 1 (4.76%) | 9 (13.04%) | 0.442 |
| SUDDEN DEATH | 2 (4.76%) | 1 (8.33%) | 6 (28.57%) | 0.012 | 1 (4.76%) | 4 (5.79%) | 1.000 |
| RECURRENCE VT | 24 (57.14%) | 4 (33.33%) | 7 (33.33%) | 0.284 | 4 (19.04%) | 8 (11.59%) | 0.464 |
| AICD SHOCK | 20 (47.61%) | – | – | – | 5 (23.81%) | – | – |
| HEART FAILURE | 13 (30.95%) | 2 (16.67%) | 6 (28.57%) | 1.000 | 2 (9.52%) | 7 (10.14%) | 1.000 |